World ADC USA 2025 is the world's largest Antibody-Drug Conjugate event focused on maximizing the therapeutic window of ADCs in oncology and beyond.
World ADC is the industry’s definitive ADC forum - from early discovery to late-phase manufacturing. Whether attendees are new to the ADC space or are an established ADC expert, the event offers insights and connections to gain unparalleled knowledge across cutting-edge R&D, end-to-end development strategy, and global market trends to progress ADCs to new standard of care treatments in oncology and beyond.
AbbVie CDMO provides Biologics manufacturing services including Antibody Drug Conjugates. From drug development to final packaging, AbbVie Contract Manufacturing is a partner with decades of exerperience that can navigate the challenges of commercial ready production, regulatory compliance, and ongoing supply chain security.
Planning to attend World ADC USA 2025? Meet with our team at the event.
Event: World ADC USA 2025
Date: November 3-6, 2025
Location: San Diego, California, USA
